Cohance Lifesciences Ltd (COHANCE) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 57.49% of Cohance Lifesciences Ltd, FIIs 6.5%, DIIs 20.09%, government 0.01% and the public 15.92%, across 99,149 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 50.1% | 50.1% | 50.1% | 66.41% | 57.49% | 57.49% | 57.49% | 57.49% |
| FIIs | 10.7% | 10.84% | 11.05% | 7.23% | 6.51% | 6.01% | 5.59% | 6.5% |
| DIIs | 16.95% | 16.67% | 16.6% | 11.4% | 20.81% | 21.57% | 21.79% | 20.09% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 22.26% | 22.37% | 22.24% | 14.95% | 15.16% | 14.91% | 15.11% | 15.92% |
| No. of Shareholders | 69,337 | 84,210 | 86,325 | 80,910 | 75,284 | 81,877 | 85,230 | 99,149 |